PortfoliosLab logoPortfoliosLab logo
Grifols, S.A. (GRFS)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US3984384087
CUSIP
398438408
IPO Date
May 17, 2006

Highlights

Market Cap
$5.46B
Enterprise Value
$13.76B
EPS (TTM)
$0.59
PE Ratio
13.66
PEG Ratio
0.22
Total Revenue (TTM)
$7.51B
Gross Profit (TTM)
$2.88B
EBITDA (TTM)
$1.60B
Year Range
$6.19 - $11.14
ROA (TTM)
2.03%
ROE (TTM)
7.61%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Grifols, S.A.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Grifols, S.A., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Grifols, S.A. (GRFS) has returned -14.22% so far this year and 14.70% over the past 12 months. Over the last ten years, GRFS has returned -5.29% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Grifols, S.A.

1D
6.08%
1M
-11.87%
YTD
-14.22%
6M
-19.48%
1Y
14.70%
3Y*
3.43%
5Y*
-12.91%
10Y*
-5.29%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 2, 2011, GRFS's average daily return is +0.04%, while the average monthly return is +0.77%. At this rate, your investment would double in approximately 7.5 years.

Historically, 50% of months were positive and 50% were negative. The best month was Nov 2022 with a return of +29.2%, while the worst month was Jan 2024 at -30.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.

On a daily basis, GRFS closed higher 50% of trading days. The best single day was Mar 8, 2024 with a return of +24.8%, while the worst single day was Jan 9, 2024 at -21.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-1.07%-1.62%-11.87%-14.22%
2025-7.39%22.50%-15.76%-2.25%19.57%8.78%18.36%-5.25%-0.10%-5.92%-5.55%5.65%27.79%
2024-30.45%-6.59%-11.05%-3.74%11.35%-11.94%18.48%25.03%-4.93%-2.14%-19.56%6.44%-35.64%
20237.18%-4.94%-14.90%1.22%10.46%11.17%19.10%-13.20%-3.48%-11.49%19.78%19.30%36.00%
20224.54%5.28%-5.50%-8.13%20.04%-7.76%-25.25%-12.50%-20.72%2.44%29.16%4.29%-24.31%
2021-4.12%-8.03%6.33%2.08%-0.91%1.29%-12.33%-4.73%0.83%-10.27%-18.15%4.66%-37.82%

Benchmark Metrics

Grifols, S.A. has an annualized alpha of 0.69%, beta of 0.77, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since June 03, 2011.

  • This stock participated in 104.48% of S&P 500 Index downside but only 69.57% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.13 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
0.69%
Beta
0.77
0.13
Upside Capture
69.57%
Downside Capture
104.48%

Return for Risk

Risk / Return Rank

GRFS ranks 51 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


GRFS Risk / Return Rank: 5151
Overall Rank
GRFS Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
GRFS Sortino Ratio Rank: 5050
Sortino Ratio Rank
GRFS Omega Ratio Rank: 4848
Omega Ratio Rank
GRFS Calmar Ratio Rank: 5151
Calmar Ratio Rank
GRFS Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Grifols, S.A. (GRFS) and compare them to a chosen benchmark (S&P 500 Index).


GRFSBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.42

0.90

-0.47

Sortino ratio

Return per unit of downside risk

0.83

1.39

-0.55

Omega ratio

Gain probability vs. loss probability

1.10

1.21

-0.11

Calmar ratio

Return relative to maximum drawdown

0.40

1.40

-1.00

Martin ratio

Return relative to average drawdown

0.95

6.61

-5.66

Explore GRFS risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Grifols, S.A. provided a 2.19% dividend yield over the last twelve months, with an annual payout of $0.18 per share.


0.00%0.50%1.00%1.50%2.00%2.50%3.00%3.50%$0.00$0.10$0.20$0.30$0.4020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.18$0.18$0.00$0.00$0.00$0.36$0.15$0.36$0.43$0.28$0.27$0.33

Dividend yield

2.19%1.88%0.00%0.00%0.00%3.20%0.83%1.55%2.32%1.24%1.67%2.01%

Monthly Dividends

The table displays the monthly dividend distributions for Grifols, S.A.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.18$0.00$0.00$0.00$0.00$0.18
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.36$0.00$0.00$0.00$0.00$0.00$0.00$0.36

Dividend Yield & Payout


Dividend Yield

Grifols, S.A. has a dividend yield of 2.19%, which is quite average when compared to the overall market.

Payout Ratio

Grifols, S.A. has a payout ratio of 31.82%, which is quite average when compared to the overall market. This suggests that Grifols, S.A. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Grifols, S.A.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Grifols, S.A. was 78.01%, occurring on Mar 6, 2024. The portfolio has not yet recovered.

The current Grifols, S.A. drawdown is 67.21%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.01%Feb 24, 20201016Mar 6, 2024
-38.75%Jul 22, 201189Nov 25, 201146Feb 2, 2012135
-37.15%Jun 10, 2014413Jan 28, 2016352Jun 21, 2017765
-28.74%Jun 13, 2018135Dec 24, 2018260Jan 7, 2020395
-19.2%Jan 29, 201861Apr 25, 201833Jun 12, 201894

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Grifols, S.A. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Grifols, S.A. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for GRFS, comparing it with other companies in the Drug Manufacturers - General industry. Currently, GRFS has a P/E ratio of 13.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for GRFS compared to other companies in the Drug Manufacturers - General industry. GRFS currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for GRFS relative to other companies in the Drug Manufacturers - General industry. Currently, GRFS has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for GRFS in comparison with other companies in the Drug Manufacturers - General industry. Currently, GRFS has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items